基本信息
views: 2
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
The Immune Regulation and Tumour Immunotherapy group at the UCL Cancer Institute aims to investigate the interplay between the immune system and cancer throughout tumour progression and immunotherapy. The use of our own immune system to specifically target cancerous cells has become a promising approach in the fight against cancer. However, anti-tumour immunity is tightly regulated by cellular and molecular circuits that prevent self and tumour destruction and significantly limit the efficacy of existing therapies.
CD4+ T cells play a key role in the regulation of immune responses to self and foreign antigens, differentiating into various subsets of helper and regulatory T cells and instructing the function of CD8+ T cells, NK cells and macrophages. Nonetheless, little is still known about the biology of tumour-reactive CD4+ T cells during tumour progression and cancer immunotherapy.
Our aim is to identify and target the most relevant cellular and molecular pathways restricting the activation of tumour-reactive lymphocytes, their access to the tumour site, and their activity within the tumour microenvironment. Moreover, we are interested in how the function and plasticity of tumour-reactive CD4+ T cells and the innate immune compartment is regulated by the tumour microenvironment and by immune co-inhibitory (e.g. CTLA-4 and PD-1) and co-stimulatory signals (e.g. GITR, OX40, CD27). In addition, we are interested in understanding how these regulatory circuits control the efficacy of cellular vaccination and adoptive cell transfer strategies and how can they be manipulated to induce potent anti-tumour immunity.
These studies will not only inform the basic understanding of the immune response to malignancies, but in the context of the UCL Cancer Institute, will be used as a platform for the development of novel translational strategies in the clinic.
CD4+ T cells play a key role in the regulation of immune responses to self and foreign antigens, differentiating into various subsets of helper and regulatory T cells and instructing the function of CD8+ T cells, NK cells and macrophages. Nonetheless, little is still known about the biology of tumour-reactive CD4+ T cells during tumour progression and cancer immunotherapy.
Our aim is to identify and target the most relevant cellular and molecular pathways restricting the activation of tumour-reactive lymphocytes, their access to the tumour site, and their activity within the tumour microenvironment. Moreover, we are interested in how the function and plasticity of tumour-reactive CD4+ T cells and the innate immune compartment is regulated by the tumour microenvironment and by immune co-inhibitory (e.g. CTLA-4 and PD-1) and co-stimulatory signals (e.g. GITR, OX40, CD27). In addition, we are interested in understanding how these regulatory circuits control the efficacy of cellular vaccination and adoptive cell transfer strategies and how can they be manipulated to induce potent anti-tumour immunity.
These studies will not only inform the basic understanding of the immune response to malignancies, but in the context of the UCL Cancer Institute, will be used as a platform for the development of novel translational strategies in the clinic.
Research Interests
Papers共 229 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
crossref(2024)
Clare Puttick,Thomas P. Jones,Michelle Leung,Oriol Pich, Felipe Galvez Cancino, Jiali Liu, Manuel Varas-Godoy,Andrew Rowan,Carlos Martinez-Ruiz,Robert Bentham,Krijn K. Dijkstra,Rachel Rosenthal,
Cancer Researchno. 6_Supplement (2024): 1201-1201
Nature Communicationsno. 1 (2024): 1-20
Nature reviews. Cancerno. 1 (2024): 51-71
crossref(2024)
Hugh O’Brien,Max Salm, Laura T Morton, Maciej Szukszto,Felix O’Farrell, Charlotte Boulton, Laurence King, Supreet Kaur Bola,Pablo Becker,Andrew Craig,Morten Nielsen,Yardena Samuels,
crossref(2024)
Roberto Vendramin,Hongchang Fu, Yue Zhao, Shanila Fernandez-Patel,Danwen Qian,Lorena Ligammari,Gordon Beattie,Ronen Levy,Polina Greenberg,Osnat Bartok,Krupa Thakkar,Jun Murai,
Cancer Researchno. 6_Supplement (2024): 6737-6737
Load More
Author Statistics
#Papers: 231
#Citation: 25323
H-Index: 62
G-Index: 137
Sociability: 7
Diversity: 3
Activity: 345
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn